Donetsk Regional Antitumor Center, Oncosurgery Department #2

Donetsk 83092

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer With Low to Intermediate HER2 Expression

Studies at this site

• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed